logo
[breadcrumb_custom]

Tag: TTOO

DOYU
News

T2 Biosystems Inc’s: Contrasting Stock Performances in a Volatile Market

The market performance of T2 Biosystems Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $70.00 on 08/16/23, with the lowest value for the same timeframe being $3.36, recorded on 03/20/24. 52-week price history of TTOO Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. T2 Biosystems Inc’s current trading price is -95.56% away from its 52-week high, while its distance from the 52-week low is -7.44%. The stock’s price range for this period has
Market Activity

T2 Biosystems (TTOO) Seeks FDA Breakthrough Device Designation for Candida Auris Test Amid Growing Global Health Concerns

T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic-resistance genes, has recently submitted an application to the U.S.  Food and Drug Administration (FDA) for Breakthrough Device Designation for its Candida auris test. This move comes as the company aims to address the urgent global health threat posed by Candida auris (C. auris), a multidrug-resistant fungal pathogen with a high mortality rate.  The potential acceleration of FDA clearance and commercialization for T2 Biosystems’ C. auris diagnostic test could position the company as a crucial player in the fight against this deadly infection. Candida Auris:

Investchronicle.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.
Facebook-f Twitter Google-plus-g Pinterest

Quick Links

Categories

©Fueled By Smart TechOne